Jobs / United States / Novartis Pharmaceuticals Corporation
Associate Director, Nonclinical Safety Assessment Expert 0ncology
Novartis Pharmaceuticals Corporation · 🇺🇸 Cambridge (USA)
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles1 certified filing for “Associate Expert Potency” (Biochemists and Biophysicists) in NJ: $89k–$89k, median $89k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary In this key role you will provide global, end to end nonclinical safety leadership across multiple modalities in the Oncology therapeutic area, ensuring scientifically robust, fit for purpose, and regulatory compliant safety strategies that enable successful clinical trial initiation and support registration. You will serve as the primary Preclinical Safety (PCS) authority on cross functional R&D teams and in interactions with global Health Authorities. You will be a critical enabler of portfolio progression, providing authoritative nonclinical safety leadership, regulatory credibility with Health Authorities, and strategic integration across therapeutic areas and modalities. Success is defined by timely clinical entry, robust regulatory outcomes, and strong cross functional trust in PCS scientific leadership. Job Description #LI-Hybrid This hybrid role is based in Cambridge, Mass with the expectation of being onsite 12 days per month. Relocation support is not provided so please only apply if this role is accessible for you. Key Responsibilities: • Lead PCS Target Teams to design, integrate, interpret, and apply nonclinical safety assessment programs, including impact on development strategy and timelines. • Represent Preclinical Safety on cross functional R&D project teams, ensuring scientifically sound and globally compliant nonclinical safety packages. • Define and implement fit for purpose, modality appropriate nonclinical programs in collaboration with PCS and external line functions. • Lead global Health Authority interactions, including negotiation on safety issues, scientific interpretation, and acceptability of nonclinical packages. • Author nonclinical safety sections of internal and regulatory documents supporting clinical development and market approval (e.g., IND/NDA). • Drive and coordinate communication strategies between PCS and R&D project teams. • Participate in internal and external cross functional initiatives advancing PCS and/or Translational Medicine objectives and current safety topics. • Support integration of in licensing and out licensing opportunities, including collaboration with BD&L and integration activities. Essential Requirements: • Advanced scientific degree (PhD, MD, DVM, PharmD, or equivalent) in Toxicology, Pharmacology, or related discipline; or DABT; or equivalent industry experience. • 5 plus years of experience as a nonclinical safety Project Team member, preferably across multiple development phases up to registration. • 8 or more years of experience in nonclinical drug development (e.g., project toxicologist, pharmacologist, study director). • Demonstrated expertise across multiple modalities (e.g., small molecules, biotherapeutics, radioligand therapies) and their safety considerations. • Proven track record of direct interaction with global Health Authorities, including IND submission writing. • Recognized scientific and regulatory expertise in nonclinical safety assessment within a global drug development context. • Demonstrated leadership and influence in complex, matrix managed, international project environments. • Strong problem solving capability in multidisciplinary, project driven settings. Desirable Experience: • Prior experience in the pharmaceutical industry • Participation in external consortia/committees relevant to drug development or safety assessment. Compensation and Benefits The salary for this position is expected to range from $ 152,600.00 - 218,000.00 - 283,400.00 USD Annual USD per year. The final salary offered is determined based on factors including relevant skills and experience and, upon joining Novartis, will be reviewed periodically. Novartis may change the published sala